Ensure you have the right content for every stage in the drug discovery pipeline with our extensive portfolio of pharmaceutical science and medical journals.
We work with 100% of the biggest drug companies ranked by Forbes¹ and 43 of the top 50 global pharma companies ranked by Pharmaceutical Executive
With over 375 titles, our medical portfolio supports the work of pharmaceutical researchers, physicians, and healthcare professionals around the world and across multiple therapy areas. Industry leaders publishing with us include GlaxoSmithKline, Johnson & Johnson, Merck, China Resources, Sanofi, Bayer, and more.
Taylor & Francis’ Food Science & Technology portfolio endeavours to support researchers and practitioners in their endeavours to improve the consumption and understanding of foods for the general public.
Offering a collection of books and journals, including the well-established journal Critical Reviews in Food Science and Nutrition on the study of the nature of food, food processing, the causes of deterioration, food safety and more,
Our Expert Collection comprises 25 peer-reviewed journals combining the well-established Expert Opinion and Expert Review series into one essential and comprehensive collection. The Expert Opinion series cover the entire R&D pipeline from drug discovery through launch and The Expert Review series represent 17 different areas of clinical medicine and is the world’s largest series of review journals in research, development and clinical medicine.